Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
Tickers IONS
Tags Briefs Biotech Movers
From Benzinga
The 7 Most Hated Stocks by Institutional Traders
Tickers GS IONS LLY PDD
Tags IONS NASDAQ:PTON,NYSE:TOST,NASDAQ:IONS,NASDAQ:TMUS,NASDAQ:PDD,NYSE:GS,NYSE:LLY LLY
From InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
Tickers ALNY IONS RHHBF RHHBY
Tags Health Care RHHVF Analyst Color
From Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Tickers ACCD ARKG ARKK ARKW
Tags Markets Market News Genius Sports
From Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
Tickers ALNY AZN IONS
Tags Price Target Expert Ideas AZN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Tickers A ABR ADBE AIV
Tags VLO BZH BPMC
From Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Tickers AAPL ADBE BAX CMCSA
Tags IONS GTLS ADBE
From Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
Tickers BIIB IONS NVS
Tags General Analyst Ratings Benzinga
From Benzinga
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
Tickers IONS NTLA
Tags Analyst Color NTLA Health Care
From Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
Tickers AZN IONS
Tags Trading Ideas News Health Care
From Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
Tickers IONS
Tags Benzinga IONS News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags ISEE SITM UPWK
From Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
Tickers IONS
Tags BZI/Recaps IONS Benzinga
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags Market News BZI/EP Earnings
From Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
Tickers BIIB IONS
Tags Market News FDA Biotech
From Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
Tickers BIIB IONS
Tags IONS BIIB
From MarketWatch
What's Going On With Biogen Stock Tuesday?
Tickers BIIB IONS
Tags Market News Earnings FDA
From Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags Briefs Guidance Market News
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags IONS ACRS Stocks to Sell
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags General News Large Cap
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags Market News AZN IONS
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags Price Target Expert Ideas Biotech
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags BXRX Briefs AZN
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags Benzinga BIIB IONS
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Tickers ADC AIZ ALLO ALNY
Tags ALNY IONS FLT
From Benzinga
Wall Street predicts approval for another ALS drug
Tickers AMLX BIIB IONS
Tags BIIB IONS AMLX
From MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
Tickers BIIB IONS
Tags General IONS BIIB
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.